NCT06893406 Cervical Myelopathy in Hip Fracture Patients
| NCT ID | NCT06893406 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Indiana University |
| Condition | Cervical Myelopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2026-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2025-05-01 with a primary completion date of 2026-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Recent evidence has demonstrated a high rate of undiagnosed cervical myelopathy in patients presenting with hip fractures from a ground level fall. Identification and treatment of cervical myelopathy can help prevent falls and future fragility fractures. The purpose of this study is to screen ground level fall hip fracture patients for cervical myelopathy using a history, physical exam, and then offer an MRI if indicated.
Eligibility Criteria
Inclusion Criteria: * Patient admitted to Eskenazi, Methodist, or IU North hospital for a hip fracture (femoral neck, intertrochanteric, subtrochanteric, or pertrochanteric fracture) that was caused by a ground level fall. Exclusion Criteria: * Neurologic or cognitive disorder explaining the fall (dementia, Parkinson's disease, delirium, etc.) * Syncopal fall or fall caused by stroke or a heart condition
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06893406 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Cervical Myelopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06893406 currently recruiting?
Yes, NCT06893406 is actively recruiting participants. Contact the research team at zgunders@iu.edu for enrollment information.
Where is the NCT06893406 trial being conducted?
This trial is being conducted at Fishers, United States, Indianapolis, United States, Indianapolis, United States.
Who is sponsoring the NCT06893406 clinical trial?
NCT06893406 is sponsored by Indiana University. The trial plans to enroll 75 participants.